Survival analysis for non-squamous NSCLC patients harbored STK11 or KEAP1 mutation receiving atezolizumab

Autor: Shang, Xiaoling, Li, Zhenxiang, Sun, Jian, Zhao, Chenglong, Lin, Jiamao, Wang, Haiyong *
Zdroj: In Lung Cancer April 2021 154:105-112
Databáze: ScienceDirect